Apr. 22, 2014
AlphaClone CEO Maz Jadallah and FBN’s Charlie Gasparino on activist Bill Ackman’s decision to team up with Valeant for a bid for Allergan.
Connect with us.
Apr. 22, 2014
AlphaClone CEO Maz Jadallah and FBN’s Charlie Gasparino on activist Bill Ackman’s decision to team up with Valeant for a bid for Allergan.
You are now leaving the AlphaClone advisor website and entering the AlphaClone ETF website. By providing this link, we are not making any representation, warranty or endorsement about the website and we are not providing you with investment advice or offering securities for sale to you.
Got it
